CLINICAL_TRIALS ClinicalTrials.gov record update

Phase I Randomised Multi-centre Study to Demonstrate the Safety of WBRT Concomitant to Intrathecal Liposomal Cytarabine (DepoCyte®) Versus WBRT & Sequential Intrathecal Liposomal Cytarabine (DepoCyte®) for Treatment of STNM With or Without Brain Metastasis.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00854867
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:32.847795+00:00
Published At: 2014-02-24T00:00:00+00:00
Record Updated At: 2014-02-24
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Solid Tumour Neoplastic Meningitis", "Brain Metastases"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2014-02-24"
protocolSection.identificationModule.nctId: "NCT00854867"
protocolSection.identificationModule.officialTitle: "Phase I Randomised Multi-centre Study to Demonstrate the Safety of WBRT Concomitant to Intrathecal Liposomal Cytarabine (DepoCyte\u00ae) Versus WBRT \u0026 Sequential Intrathecal Liposomal Cytarabine (DepoCyte\u00ae) for Treatment of STNM With or Without Brain Metastasis."
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.